Norges Bank Puma Biotechnology, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$7.01 - $13.24 $2.26 Million - $4.26 Million	-321,802 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$6.28 - $14.57 $2.02 Million - $4.69 Million	321,802 New	321,802 $2.72 Million
Q1 2020 May 08, 2020	SELL	$6.28 - $14.57 $2.28 Million - $5.29 Million	-363,202 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$6.5 - $10.73 $2.36 Million - $3.9 Million	363,202 New	363,202 $3.18 Million
Q4 2019 Feb 12, 2020	SELL	$6.5 - $10.73 $2.92 Million - $4.82 Million	-449,217 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$8.75 - $12.85 $3.93 Million - $5.77 Million	449,217 New	449,217 $4.84 Million
Q3 2019 Nov 08, 2019	SELL	$8.75 - $12.85 $5.74 Million - $8.42 Million	-655,437 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$12.3 - $35.76 $8.06 Million - $23.4 Million	655,437 New	655,437 $8.33 Million
Q2 2019 Aug 09, 2019	SELL	$12.3 - $35.76 $8.06 Million - $23.4 Million	-655,437 Closed	0 $0
Q1 2019 May 11, 2020	SELL	$20.77 - $42.37 $389,229 - $794,013	-18,740 Reduced 2.78%	655,437 $25.4 Million
Q4 2018 Mar 04, 2019	BUY	$20.07 - $46.7 $13.5 Million - $31.5 Million	674,177 New	674,177 $13.7 Million
Q4 2018 Feb 08, 2019	SELL	$20.07 - $46.7 $15.2 Million - $35.4 Million	-756,992 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$41.2 - $59.85 $31.2 Million - $45.3 Million	756,992 New	756,992 $34.7 Million
Q3 2018 Nov 09, 2018	SELL	$41.2 - $59.85 $31.2 Million - $45.3 Million	-756,992 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$48.3 - $68.25 $36.6 Million - $51.7 Million	756,992 New	756,992 $44.8 Million
Q2 2018 Jul 23, 2018	SELL	$48.3 - $68.25 $41.2 Million - $58.2 Million	-853,123 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$59.7 - $99.25 $50.9 Million - $84.7 Million	853,123 New	853,123 $58.1 Million
Q1 2018 May 09, 2018	SELL	$59.7 - $99.25 $42.7 Million - $71.1 Million	-716,003 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$93.85 - $132.45 $67.2 Million - $94.8 Million	716,003 New	716,003 $70.8 Million
Q4 2017 Feb 09, 2018	SELL	$93.85 - $132.45 $59.9 Million - $84.5 Million	-638,135 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$72.0 - $119.75 $45.9 Million - $76.4 Million	638,135 New	638,135 $76.4 Million
Q3 2017 Nov 07, 2017	SELL	$72.0 - $119.75 $36.1 Million - $60 Million	-501,322 Closed	0 $0
Q2 2017 Jul 24, 2018	BUY	N/A	108,443 Added 27.6%	501,322 $43.8 Million
Q1 2017 May 11, 2018	BUY	N/A	196,705 Added 100.27%	392,879 $14.6 Million
Q3 2016 Nov 13, 2017	BUY	N/A	196,174	196,174 $0

Others Institutions Holding PBYI

# of Institutions

102

Shares Held

29.1M

Call Options Held

60.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$10.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.4 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$8.88 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.35 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.71 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account